Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysisMykhailo Buchynskyi, Oleksandr Kamyshnyi, Katerina Lyubomirskaya et al.|Frontiers in Immunology|2023Cited by 37
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian ExperienceOleksandr Kamyshnyi, Olena Moshynets, G. D. Koval et al.|International Journal of Molecular Sciences|2023Cited by 25
Azithromycin possesses biofilm–inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumoniaOlena Moshynets, Andrew J. Spiers, Taras P. Baranovskyi et al.|PLoS ONE|2022Cited by 16
Case report: Azithromycin-meropenem combination therapy as a low-cost approach to combat PDR gram-negative infections of war wounds in UkraineV. V. Kryzhevskyi, Olena Moshynets, Viktor Strokous et al.|Frontiers in Medicine|2023Cited by 10
Therapeutic Effectiveness of Interferon-α2b Against COVID-19 with community-acquired pneumonia: The Ukrainian ExperienceOleksandr Kamyshnyi, Olena Moshynets, G. D. Koval et al.|Unknown|2022Cited by 8